Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Hong, Qianhong Li, Yiru Guo, Nikita Patton, Afsoon Moktar, A. Bhatnagar, R. Bolli (2013)
A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in miceBasic Research in Cardiology, 108
K. Laugwitz, A. Moretti, J. Lam, P. Gruber, Yinhong Chen, S. Woodard, Lizhu Lin, C. Cai, M. Lu, M. Reth, O. Platoshyn, J. Yuan, S. Evans, K. Chien (2005)
Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineagesNature, 433
K. Chien, I. Domian, K. Parker (2008)
Cardiogenesis and the Complex Biology of Regenerative Cardiovascular MedicineScience, 322
Lepeng Zeng, Qingsong Hu, Xiaohong Wang, A. Mansoor, Joseph Lee, Julia Feygin, Ge Zhang, P. Suntharalingam, S. Boozer, A. Mhashilkar, C. Panetta, C. Swingen, R. Deans, A. From, R. Bache, C. Verfaillie, Jianyi(Jay) Zhang (2007)
Bioenergetic and Functional Consequences of Bone Marrow-Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular RemodelingCirculation, 115
C. Cai, Xingqun Liang, Yunqing Shi, Po-Hsien Chu, S. Pfaff, Ju Chen, S. Evans (2003)
Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart.Developmental cell, 5 6
J. Terrovitis, R. Lautamäki, M. Bonios, J. Fox, J. Engles, Jianhua Yu, Michelle Leppo, M. Pomper, R. Wahl, J. Seidel, B. Tsui, F. Bengel, M. Abraham, E. Marbán (2009)
Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery.Journal of the American College of Cardiology, 54 17
Xiaohong Wang, Qingsong Hu, Yasuhiro Nakamura, Joseph Lee, Ge Zhang, A. From, Jianyi(Jay) Zhang (2006)
The Role of the Sca‐1+/CD31− Cardiac Progenitor Cell Population in Postinfarction Left Ventricular RemodelingSTEM CELLS, 24
Amit Patel, T. Henry, A. Quyyumi, G. Schaer, R. Anderson, C. Toma, C. East, A. Remmers, J. Goodrich, Akshay Desai, D. Recker, A. DeMaria (2016)
Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trialThe Lancet, 387
S. Sahoo, Ekaterina Klychko, T. Thorne, S. Misener, K. Schultz, Meredith Millay, A. Ito, Ting Liu, C. Kamide, Hemant Agrawal, H. Perlman, G. Qin, R. Kishore, Douglas Losordo (2011)
Exosomes From Human CD34+ Stem Cells Mediate Their Proangiogenic Paracrine ActivityCirculation Research, 109
A. Aicher, C. Heeschen, Ken-ichiro Sasaki, C. Urbich, A. Zeiher, S. Dimmeler (2006)
Low-Energy Shock Wave for Enhancing Recruitment of Endothelial Progenitor Cells: A New Modality to Increase Efficacy of Cell Therapy in Chronic Hind Limb IschemiaCirculation, 114
G. Keller (2005)
Embryonic stem cell differentiation: emergence of a new era in biology and medicine.Genes & development, 19 10
K. Wollert, G. Meyer, J. Lotz, Stefanie Lichtenberg, P. Lippolt, C. Breidenbach, S. Fichtner, T. Korte, B. Hornig, D. Messinger, L. Arseniev, B. Hertenstein, A. Ganser, H. Drexler (2004)
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trialThe Lancet, 364
Q. Xiong, K. Hill, Qinglu Li, P. Suntharalingam, A. Mansoor, Xiaohong Wang, M. Jameel, Pengyuan Zhang, C. Swingen, D. Kaufman, Jianyi(Jay) Zhang (2011)
A Fibrin Patch‐Based Enhanced Delivery of Human Embryonic Stem Cell‐Derived Vascular Cell Transplantation in a Porcine Model of Postinfarction Left Ventricular RemodelingSTEM CELLS, 29
M. Gnecchi, Zhiping Zhang, Aiguo Ni, V. Dzau (2008)
Paracrine Mechanisms in Adult Stem Cell Signaling and TherapyCirculation Research, 103
S Fukuhara, S Tomita, T Nakatani (2005)
Bone marrow cell-seeded biodegradable polymeric scaffold enhances angiogenesis and improves function of the infarcted heartCirc. J., 69
G. Condorelli, D. Catalucci (2007)
Human stem cells for heart failure treatment ready for prime time?Journal of the American College of Cardiology, 50 19
M. Haan, R. Grauss, A. Smits, E. Winter, J. Tuyn, D. Pijnappels, P. Steendijk, A. Groot, A. Laarse, W. Fibbe, A. Vries, M. Schalij, P. Doevendans, M. Goumans, D. Atsma (2012)
Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse heartsJournal of Cellular and Molecular Medicine, 16
Kazutoshi Takahashi, S. Yamanaka (2006)
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 126
H. Hata, A. Bär, Suzanne Dorfman, Z. Vukadinovic, Y. Sawa, A. Haverich, A. Hilfiker (2010)
Engineering a novel three-dimensional contractile myocardial patch with cell sheets and decellularised matrix.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 38 4
S. Fazel, M. Cimini, Liwen Chen, Shu‐hong Li, D. Angoulvant, P. Fedak, S. Verma, R. Weisel, A. Keating, Ren-Ke Li (2006)
Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.The Journal of clinical investigation, 116 7
B. Assmus, A. Rolf, S. Erbs, A. Elsässer, W. Haberbosch, R. Hambrecht, H. Tillmanns, Jiangtao Yu, R. Corti, D. Mathey, C. Hamm, T. Süselbeck, T. Tonn, S. Dimmeler, T. Dill, A. Zeiher, V. Schächinger (2010)
Clinical Outcome 2 Years After Intracoronary Administration of Bone Marrow–Derived Progenitor Cells in Acute Myocardial InfarctionCirculation: Heart Failure, 3
Maribella Domenech, Lilliana Polo-Corrales, J. Ramirez-Vick, D. Freytes (2016)
Tissue Engineering Strategies for Myocardial Regeneration: Acellular Versus Cellular Scaffolds?Tissue engineering. Part B, Reviews, 22 6
J. Houtgraaf, W. Dekker, B. Dalen, T. Springeling, R. Jong, R. Geuns, M. Geleijnse, F. Fernández‐Avilés, Felix Zijlsta, P. Serruys, H. Duckers (2012)
First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction.Journal of the American College of Cardiology, 59 5
Jennifer Singelyn, Priya Sundaramurthy, Todd Johnson, Pamela Schup-Magoffin, D. Hu, D. Faulk, Jean Wang, Kristine Mayle, Kendra Bartels, Michael Salvatore, A. Kinsey, A. DeMaria, N. Dib, K. Christman (2012)
Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction.Journal of the American College of Cardiology, 59 8
J. Mignone, K. Kreutziger, Sharon Paige, C. Murry (2010)
Cardiogenesis from human embryonic stem cells.Circulation journal : official journal of the Japanese Circulation Society, 74 12
(2006)
Multipotent Embryonic Isl1 + Progenitor Cells Lead to Cardiac, Smooth Muscle, and Endothelial Cell DiversificationCell, 127
L. Balsam, A. Wagers, J. Christensen, T. Kofidis, I. Weissman, R. Robbins (2004)
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardiumNature, 428
S Mansour, DC Roy, V Bouchard, BK Nguyen, LM Stevens, F Gobeil (2010)
COMPARE-AMI Trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute MI and left ventricular dysfunction: study rationale and designJ. Cardiovasc. Transl. Res., 3
E. Messina, L. Angelis, G. Frati, S. Morrone, S. Chimenti, F. Fiordaliso, M. Salio, M. Battaglia, M. Latronico, M. Coletta, E. Vivarelli, L. Frati, G. Cossu, A. Giacomello (2004)
Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine HeartCirculation Research, 95
H. Oh, Steven Bradfute, T. Gallardo, Teruya Nakamura, V. Gaussin, Y. Mishina, J. Pocius, L. Michael, R. Behringer, D. Garry, M. Entman, M. Schneider (2003)
Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarctionProceedings of the National Academy of Sciences of the United States of America, 100
Kaytlyn Gerbin, Xiulan Yang, C. Murry, Kareen Coulombe (2015)
Enhanced Electrical Integration of Engineered Human Myocardium via Intramyocardial versus Epicardial Delivery in Infarcted Rat HeartsPLoS ONE, 10
Chun-yu Li, Xiao-yun Wu, Jia-bei Tong, Xin-xin Yang, Jing-li Zhao, Quan-fu Zheng, Guoha Zhao, Zhi-jie Ma (2015)
Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapyStem Cell Research & Therapy, 6
S. Janssens, C. Dubois, J. Bogaert, K. Theunissen, C. Deroose, W. Desmet, M. Kalantzi, L. Herbots, P. Sinnaeve, J. Dens, J. Maertens, F. Rademakers, S. Dymarkowski, O. Gheysens, J. Cleemput, G. Bormans, J. Nuyts, A. Belmans, L. Mortelmans, M. Boogaerts, F. Werf (2006)
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trialThe Lancet, 367
R. Bolli, A. Chugh, D. D’Amario, J. Loughran, M. Stoddard, Sohail Ikram, G. Beache, S. Wagner, A. Leri, T. Hosoda, Fumihiro Sanada, Julius Elmore, P. Goichberg, D. Cappetta, N. Solankhi, Ibrahim Fahsah, D. Rokosh, M. Slaughter, J. Kajstura, P. Anversa (2011)
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trialThe Lancet, 378
H. Kamihata, Hiroaki Matsubara, T. Nishiue, S. Fujiyama, Y. Tsutsumi, Ryozo Ozono, Hiroya Masaki, Yasukiyo Mori, O. Iba, E. Tateishi, A. Kosaki, Satoshi Shintani, T. Murohara, T. Imaizumi, T. Iwasaka (2001)
Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and CytokinesCirculation: Journal of the American Heart Association, 104
K. Matsuura, T. Nagai, Nobuhiro Nishigaki, T. Oyama, Jun-ichiro Nishi, H. Wada, Masanori Sano, H. Toko, H. Akazawa, Toshiaki Sato, H. Nakaya, H. Kasanuki, I. Komuro (2013)
Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes.The Journal of Biological Chemistry, 288
R. Hassink, J. Dowell, A. Rivière, P. Doevendans, L. Field (2003)
Stem cell therapy for ischemic heart disease.Trends in molecular medicine, 9 10
Rajeswari Ravichandran, J. Venugopal, S. Mukherjee, S. Sundarrajan, S. Ramakrishna (2015)
Elastomeric core/shell nanofibrous cardiac patch as a biomimetic support for infarcted porcine myocardium.Tissue engineering. Part A, 21 7-8
P. Maureira, P. Marie, Fengxu Yu, S. Poussier, Yihua Liu, Frédérique Groubatch, Aude Falanga, N. Tran (2012)
Repairing chronic myocardial infarction with autologous mesenchymal stem cells engineered tissue in rat promotes angiogenesis and limits ventricular remodelingJournal of Biomedical Science, 19
K. Malliaras, R. Makkar, R. Smith, K. Cheng, E. Wu, R. Bonow, L. Marbán, A. Mendizabal, E. Cingolani, Peter Johnston, G. Gerstenblith, K. Schuleri, A. Lardo, E. Marbán (2014)
Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction).Journal of the American College of Cardiology, 63 2
A. Chugh, G. Beache, J. Loughran, N. Mewton, Julius Elmore, J. Kajstura, P. Pappas, A. Tatooles, M. Stoddard, J. Lima, M. Slaughter, P. Anversa, R. Bolli (2012)
Administration of Cardiac Stem Cells in Patients With Ischemic Cardiomyopathy: The SCIPIO Trial Surgical Aspects and Interim Analysis of Myocardial Function and Viability by Magnetic ResonanceCirculation, 126
G. Meyer, K. Wollert, J. Lotz, Jens Pirr, Ulrike Rager, P. Lippolt, A. Hahn, S. Fichtner, A. Schaefer, L. Arseniev, A. Ganser, H. Drexler (2009)
Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial.European heart journal, 30 24
S. Ong, Won Lee, Mei Huang, Devaveena Dey, K. Kodo, Veronica Sanchez-Freire, Joseph Gold, Joseph Wu (2014)
Cross Talk of Combined Gene and Cell Therapy in Ischemic Heart Disease: Role of Exosomal MicroRNA TransferCirculation, 130
A. Beltrami, Laura Barlucchi, D. Torella, M. Baker, F. Limana, S. Chimenti, H. Kasahara, M. Rota, E. Musso, K. Urbanek, A. Leri, J. Kajstura, B. Nadal-Ginard, P. Anversa (2003)
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial RegenerationCell, 114
A. Ibrahim, K. Cheng, E. Marbán (2014)
Exosomes as Critical Agents of Cardiac Regeneration Triggered by Cell TherapyStem Cell Reports, 2
S. Fukuhara, S. Tomita, T. Nakatani, T. Fujisato, Y. Ohtsu, M. Ishida, C. Yutani, S. Kitamura (2005)
Current address: Shinji Tomita, MD, Cardiothoracic Surgical Unit, Level 4, Auckland City Hospital, Auckland, New ZealandCirculation, 69
B. Assmus, D. Walter, F. Seeger, D. Leistner, J. Steiner, I. Ziegler, A. Lutz, Walaa Khaled, J. Klotsche, T. Tonn, S. Dimmeler, A. Zeiher (2013)
Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.JAMA, 309 15
T. Dill, V. Schächinger, A. Rolf, S. Möllmann, H. Thiele, H. Tillmanns, B. Assmus, S. Dimmeler, A. Zeiher, C. Hamm (2009)
Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute MyocardialAmerican heart journal, 157 3
J. Bartunek, A. Behfar, D. Dolatabadi, M. Vanderheyden, M. Ostojić, J. Dens, B. Nakadi, M. Banovic, B. Beleslin, M. Vrolix, V. Legrand, C. Vrints, J. Vanoverschelde, R. Crespo-Diaz, C. Homsy, M. Tendera, S. Waldman, W. Wijns, A. Terzic (2013)
Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.Journal of the American College of Cardiology, 61 23
D. Simpson, N. Boyd, S. Kaushal, S. Stice, S. Dudley (2012)
Use of human embryonic stem cell derived‐mesenchymal cells for cardiac repairBiotechnology and Bioengineering, 109
K. Lunde, S. Solheim, S. Aakhus, H. Arnesen, M. Abdelnoor, T. Egeland, K. Endresen, A. Ilebekk, A. Mangschau, J. Fjeld, H. Smith, E. Taraldsrud, H. Grøgaard, R. Bjørnerheim, M. Brekke, C. Müller, E. Hopp, A. Ragnarsson, J. Brinchmann, K. Forfang (2006)
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.The New England journal of medicine, 355 12
M. Konoplyannikov, V. Kalsin, A. Averyanov, A. Troitsky (2016)
Stem Cell Therapy of Ischemic Heart DiseaseJournal of Biomedical Science and Engineering, 09
Yuliang Feng, Wei Huang, M. Wani, Xi-Yong Yu, M. Ashraf (2014)
Ischemic Preconditioning Potentiates the Protective Effect of Stem Cells through Secretion of Exosomes by Targeting Mecp2 via miR-22PLoS ONE, 9
Jingbo Liu, Qingsong Hu, Zong-qian Wang, Chengsu Xu, Xiaohong Wang, G. Gong, A. Mansoor, Joseph Lee, Mingxiao Hou, Lepeng Zeng, John Zhang, M. Jerosch-Herold, Tao Guo, R. Bache, Jianyi(Jay) Zhang (2004)
Autologous stem cell transplantation for myocardial repair.American journal of physiology. Heart and circulatory physiology, 287 2
H. Wei, Chun-Hung Chen, W. Lee, I. Chiu, Shiaw-Min Hwang, Wei-Wen Lin, Chieh-Cheng Huang, Yi-Chun Yeh, Yen Chang, Hsing‐Wen Sung (2008)
Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair.Biomaterials, 29 26
D. Orlic, J. Kajstura, S. Chimenti, Igor Jakoniuk, S. Anderson, Baosheng Li, J. Pickel, R. McKay, B. Nadal-Ginard, D. Bodine, A. Leri, P. Anversa (2001)
Bone marrow cells regenerate infarcted myocardiumNature, 410
Nathaniel Tulloch, V. Muskheli, M. Razumova, F. Korte, Michael Regnier, K. Hauch, Lil Pabon, H. Reinecke, C. Murry (2011)
Growth of Engineered Human Myocardium With Mechanical Loading and Vascular CocultureCirculation Research, 109
D. Kai, Qiang-li Wang, Hai-jie Wang, M. Prabhakaran, Yanzhong Zhang, Yu-zhen Tan, S. Ramakrishna (2014)
Stem cell-loaded nanofibrous patch promotes the regeneration of infarcted myocardium with functional improvement in rat model.Acta biomaterialia, 10 6
K Malliaras, RR Makkar, RR Smith (2014)
Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS TrialJ. Am. Coll. Cardiol., 63
R. Smith, L. Barile, Hee Cho, Michelle Leppo, Joshua Hare, E. Messina, A. Giacomello, M. Abraham, E. Marbán (2007)
Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy SpecimensCirculation, 115
C. Théry, L. Zitvogel, S. Amigorena (2002)
Exosomes: composition, biogenesis and functionNature Reviews Immunology, 2
K. Urbanek, F. Quaini, G. Tasca, D. Torella, C. Castaldo, B. Nadal-Ginard, A. Leri, J. Kajstura, E. Quaini, P. Anversa (2003)
Intense myocyte formation from cardiac stem cells in human cardiac hypertrophyProceedings of the National Academy of Sciences of the United States of America, 100
T Dill, V Schächinger, A Rolf (2009)
Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudyAm. Heart J., 157
S. Mansour, D. Roy, Vincent Bouchard, B. Nguyen, L. Stevens, F. Gobeil, A. Rivard, G. Leclerc, F. Reeves, N. Noiseux (2010)
COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients After Acute Myocardial Infarction and Left Ventricular Dysfunction: Study Rationale and DesignJournal of Cardiovascular Translational Research, 3
S. Mansour, D. Roy, Vincent Bouchard, L. Stevens, F. Gobeil, A. Rivard, G. Leclerc, F. Reeves, N. Noiseux (2011)
One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular DysfunctionBone Marrow Research, 2011
The prevalence of heart failure (HF) is continuously rising in both the industrialized and non-industrialized nations. Despite current therapeutic advances, prognosis of HF patients remains poor. Presently, therapeutic pharmacological and device strategies for HF with reduced ejection fraction (HFrEF) are mostly palliative and do not induce regeneration of lost myocardial tissue. Stem cell therapy has demonstrated promising results in clinical studies by promoting myocardial restoration in HFrEF subjects. Despite decades of investigation, many challenges remain unanswered to the widespread clinical application of stem cell therapy for HFrEF. This review will describe the foundational work already accomplished in cardiac stem cell therapy, advantages and limitations of the various candidates for tissue restoration, their presumed mechanisms of action, the role of scaffolding materials as well as the challenges that exist for widespread clinical application.
Cardiovascular Engineering and Technology – Springer Journals
Published: Aug 28, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.